Skip to main content

Month: August 2023

Mosaic Minerals Begins Prospection Work on Lithium SM

Lithium SM Mapped PegmatitesLithium SM Mapped PegmatitesMONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “the Company”) is pleased to announce the start of prospecting work on the Lithium SM project after several weeks of delays caused by forest fires. Covering 10,864 hectares (194 cells) and located 40 km north of the Quévillon mining sector, this project is easily accessible by forest and secondary roads linking Quévillon to Matagami. The Lithium SM property, 20 kilometers long by approximately 10 kilometers high, is intersected in its center by an EW fault as well as by a few faults trending ENE. In the southern part of the property, numerous lithium anomalies associated directly with pegmatites currently suggest a favorable horizon of more than 5 kilometers.At the center...

Continue reading

Reborn Coffee to Present at H.C. Wainwright 25th Annual Global Investment Conference on September 11, 2023

BREA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) — Reborn Coffee, Inc. (NASDAQ: REBN) (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, today announced today it will participate at the H.C. Wainwright 25th Annual Global Investment Conference September 11–12, 2023. Reborn Coffee Chief Executive Officer Jay Kim, Vice Chairman of the Board of Directors Dennis Egidi, Advisory Board Member Bill Koschak and Senior Vice President William Kim will conduct 30-minute meetings during the H.C. Wainwright 25th Annual Global Investment Conference. Senior Vice President William Kim will deliver the Company’s presentation at the H.C. Wainwright Global Investment Conference, which can be viewed on-demand at the webcast link below beginning Monday, September 11 at 7:00 AM ET and will also be available on the Reborn Coffee...

Continue reading

Solar Integrated Roofing Corp. Eliminates Over $1.5 Million of Debt

HENDERSON, Nev., Aug. 30, 2023 (GLOBE NEWSWIRE) — Solar Integrated Roofing Corp. (OTC:SIRC) (“SIRC” or the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems, today announced it has completed a 3a10 transaction with Continuation Capital with final numbers as follows:Total debt retired: $1,063,778 Total shares initially reserved for transaction: 239,239,890 Total shares issued for transaction: 144,302,020The Company also settled an outstanding secured debt with an existing creditor, a factor for $469,000 of its receivables. The company also settled a note with an individual lender retiring $150,000 in debt. “These transactions have allowed us to retire a significant amount of outstanding liabilities, including the entirety of debt balances with five different creditors,”...

Continue reading

Tingo Group to Host Second Quarter 2023 Results Conference Call on Thursday August 31, 2023 at 8:00 a.m. Eastern Time

MONTVALE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) — Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”), a profitable and fast growing fintech and agri-fintech company, today announced that it will hold a conference call on Thursday August 31, 2023 at 8:00 a.m. Eastern Time to present its results for the second quarter ended June 30, 2023 and provide a business update. A press release detailing the results will be issued prior to the call. A presentation will accompany the conference call, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here. The conference call will be followed by a question-and-answer period. Questions will be accepted leading up to the call and can be submitted via email to TIO@mzgroup.us. To access the call, please use the following information:Date: Thursday...

Continue reading

Vera Bradley Announces Second Quarter Fiscal Year 2024 Results

Consolidated net revenues totaled $128.2 million Net income totaled $9.3 million, or $0.30 per diluted share; non-GAAP net income totaled $10.2 million, or $0.33 per diluted share Balance sheet strengthens, with cash and cash equivalents of $48.5 million, no debt, and year-over-year inventories down 22.4% FORT WAYNE, Ind., Aug. 30, 2023 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) today announced its financial results for the second quarter and six months ended July 29, 2023. In this release, Vera Bradley, Inc. or “the Company” refers to the entire enterprise and includes both the Vera Bradley and Pura Vida brands. Vera Bradley on a stand-alone basis refers to the Vera Bradley brand. Second Quarter Comments Jackie Ardrey, Chief Executive Officer of the Company, noted, “Our transformational efforts continue to bear fruit...

Continue reading

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

Company focused on accelerating clinical programs for PORT-2, PORT-6, and PORT-7 WESTPORT, Conn., Aug. 30, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended June 30, 2023. “In recent weeks we have continued to build on the favorable interim data and early evidence of single agent activity from the Phase 1/2 trial of our lead program, PORT-2, presented at the 2023 annual meeting of the American Society for Clinical Oncology (ASCO) in June, and our near-term focus is defining the recommended Phase 2 dose,” said Dr. Ian Walters, Chief Executive Officer, and Chairman of Portage Biotech. “We have transferred sponsorship of the clinical trial...

Continue reading

Golden Grail Beverages Elevates Digital Experience with Website Relaunch

FORT LAUDERDALE, Fla., Aug. 30, 2023 (GLOBE NEWSWIRE) — Golden Grail Technology, doing business as Golden Grail Beverages (OTC: GOGY) is proud to announce the official launch of its newly redesigned website, www.goldengrailbeverages.com. The site boasts visually appealing portfolio pages, engaging blogs, a dedicated investor hub, and an upcoming e-commerce section. The website’s modern design offers a fresh and intuitive user experience tailored for today’s consumers with detailed descriptions and captivating images. The streamlined navigation system ensures easy access to information, while the mobile-responsive design guarantees seamless browsing across all devices. One of the standout features is the visually appealing portfolio pages, which showcase Golden Grail Beverages’ diverse range of products. Golden...

Continue reading

Clene to Present at Upcoming September Conferences

SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September. H.C. Wainwright 25th Annual Global Investment ConferenceDate: September 11-13, 2023Location: Lotte New York Palace Hotel, New York, NYDate and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ETFormat: Corporate Presentation and 1×1 meetingsWebcast Link: https://journey.ct.events/view/3eb50cf4-1561-4363-8e78-ac2c56092fb6 Cantor...

Continue reading

Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients

Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Aug. 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and related solutions company, today announced that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for NLC Pharma’s patent application entitled “Compounds for Treating a Coronavirus Infection” prosecuted from the groundbreaking work of Dr. Dorit Arad. The Notice of Allowance covers the use of key compounds contained in the ingredients in Tollovid™ and Tollovir™ (NLC-V-01, NLC-001 or 3CL-001).  The allowed claims are directed, among other things, to the administration of compounds to a subject...

Continue reading

Perspective Therapeutics to Present at the World Molecular Imaging Congress 2023

RICHLAND, WASH. & CORALVILLE, IOWA, Aug. 30, 2023 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced that it will have two presentations at the upcoming World Molecular Imaging Congress (WMIC) 2023, hosted by the World Molecular Imaging Society (WMIS). The conference is being held in Prague, Czech Republic, from September 5-9, 2023. “We are pleased with our team’s progress in pioneering the development of promising image-guided, lead-based, alpha particle therapies.” said Thijs Spoor, Chief Executive Officer at Perspective Therapeutics. “Our team continues to deepen our pipeline with exceptional data from our novel radioligand, [203/212Pb]PSC-PEG3-Adma, for image-guided pre-targeted alpha particle therapy; and our preclinical data for our lead-based alpha...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.